Refractive

EssilorLuxottica announced six-month interim clinical trial results on September 22, 2026, showing that Essilor Stellest 2.0 spectacle lenses achieved treatment effects of 0.51 D for myopia progression and 0.21 mm for axial elongation compared to single-vision lenses in children. The randomized, double-masked study in China demonstrated that the newer lenses matched the 12-month efficacy of … Read more